Tadalafil + Placebo + Tamsulosin

Phase 2Completed
0 watching 0 views this week Active
52
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Benign Prostatic Hyperplasia

Conditions

Benign Prostatic Hyperplasia

Trial Timeline

Oct 1, 2007 → Jun 1, 2008

About Tadalafil + Placebo + Tamsulosin

Tadalafil + Placebo + Tamsulosin is a phase 2 stage product being developed by Eli Lilly for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT00540124. Target conditions include Benign Prostatic Hyperplasia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT00861757Phase 3Completed
NCT00540124Phase 2Completed

Competing Products

20 competing products in Benign Prostatic Hyperplasia

See all competitors